Design Therapeutics Inc (DSGN) support and resistance · $214.0M cap
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
This page maps Design Therapeutics Inc (DSGN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported DSGN revenue for 2025-09-30 was $0. Net income was -$53.8M. DSGN currently screens at market cap $214.0M.
DSGN currently screens at market cap $214.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DSGN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DSGN quote page for the session range and the stock page for the full model.
Not investment advice.